(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Mahanth Joishy recounts his battle with Sézary Syndrome, an extremely rare form of cancer that affects the skin, and how he ...

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on rare diseases, announced that a comprehensive summary of clinical trials evaluating HyBryte(TM) (synthetic hypericin) for ...

Michelle Smith was told she had eczema as a teenager but her skin condition gradually worsened over years - until doctors ...

The belief that surgery spreads cancer is a common public misconception. Onco-surgeon Yogeshwar Shukla spoke to Free Press on cancer treatment and misconceptions. Excerpts: There is a perception that ...

AUSTIN, Texas, March 19, 2026 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public ...

Adults with moderate to severe plaque psoriasis saw the greatest mean quality-of-life gains with biologic therapy whereas ...

Prescient Therapeutics Ltd (ASX:PTX) is advancing enrolment in its Phase 2 clinical trial for lead asset PTX-100, with new research highlighting steady progress across trial execution, regulatory ...

For Jim Cowdell, it was three strikes, and he’s out. After 40 years as a public servant in the city, Cowdell will retire as executive director of EDIC/Lynn as of June 1. He announced his decision to ...

Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

In this study, researchers aimed to characterize the mutational landscape of the tumors of domestic cats to determine whether similarities to humans could translate to the clinic.